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ABStr ACt
Background New or worsening cognitive, physical and/or 
mental health impairments after acute care for critical illness 
are referred to as “post-intensive care syndrome” (PICS). Little 
is known about the incidence of its components, since it is chal-
lenging to recruit patients after intensive care unit (ICU) treat-
ment for observational studies. Claims data are particularly 
suited to achieve incidence estimates in difficult-to-recruit 
groups. However, some limitations remain when using claims 
data for empirical research on the outcome of ICU treatment. 
The objective of this article is to describe three challenges and 
possible solutions for the estimation of the incidence of PICS 
based on claims data 
Methodological challenges: The presence of competing 
risk by death, investigating a syndrome and dealing with 
interval censoring First, in (post) ICU populations the assump-
tion of independence between the event of interest (diagnosis 
of PICS component) and the competing event (death) is violated. 
Competing risk is an event whose occurrence precludes the 
event of interest to be observed, and in ICU populations, death 
is a frequent secondary event. Methods that estimate incidence 
in the presence of competing risks are well-established but have 
not been applied to the scenario described above. Second, PICS 
is a complex syndrome and represented by various ICD-10 (In-
ternational Classification of Diseases, 10th Revision) disease 
codes. The operationalization of this syndrome (case identifica-
tion) and the validation of cases are particularly challenging. 
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Third, another major challenge is that the exact date of the event 
of interest is not available in claims data. It is only known that the 
event occurred within a certain interval. This feature is called 
interval censoring. Recently, methods have been developed that 
address informative censoring due to competing risks in the 
presence of interval censoring. We will discuss how these meth-
ods could be used to tackle the problem when estimating PICS 
components. Alternatively, it could be possible to assign an exact 
date for each diagnosis by combining the diagnosis with the ex-
act date of prescriptions of the respective medicines and/or 
medical services.
Conclusion Estimating incidence in post-ICU populations en-
tails various methodological issues when using claims data. 
Investigators need to be aware of the presence of competing 
risks. The application of internal validation criteria to opera-
tionalize the event of interest is crucial to achieve reliable inci-
dence estimates. The problem of interval censoring can be 
solved either by statistical methods or by combining informa-
tion from different sources.
ZuSAMMEnfASSung
Hintergrund Neue oder sich verschlechternde kognitive, 
körperliche und/oder psychische Folgeerkrankungen nach der 
Behandlung kritischer Erkrankungen auf der Intensivstation 
(ICU) werden als „Post-Intensiv-Syndrom“ (PICS) bezeichnet. 
Die Rekrutierung von ehemaligen Intensivpatienten für Beob-
achtungsstudien gestaltet sich oftmals als schwierig, weshalb 
kaum Informationen zur Inzidenz einzelner Komponenten 
dieses Syndroms vorliegen. (GKV-)Routinedaten sind daher 
besonders gut geeignet, um Inzidenzschätzungen an solchen 
schwer zu rekrutierenden Gruppen durchzuführen. Allerdings 
gibt es einige methodische Herausforderungen, die adressiert 
werden müssen, wenn man empirische Forschung zu Folgen 
von Intensivaufenhalten auf Basis von Routinedaten durchfüh-
ren möchte. Ziel dieser Arbeit ist es, 3 wesentliche Heraus-
forderungen und mögliche Lösungen für die Schätzung der 
Inzidenz von PICS auf Grundlage von GKV-Routinedaten zu 
beschreiben.
Methodische Herausforderungen Konkurrierendes Risiko 
durch Versterben, die Untersuchung eines Syndroms und der 
Umgang mit Intervallzensierung.
Erstens wird in (Post-)ICU-Populationen die Annahme der 
Unabhängigkeit zwischen dem interessierenden Ereignis 
(Diagnose der PICS-Komponente) und dem konkurrierenden 
Ereignis (Tod) verletzt. Das konkurrierende Risiko (compe-
ting risk) ist ein Ereignis, dessen Auftreten das zu beobach-
tende Ereignis von Interesse ausschließt. Das konkurrierende 
Ereignis bleibt häufig unberücksichtigt, aber in ICU-Popula-
tionen ist das Versterben ein häufiges sekundäres Ereignis. 
Methoden zur Schätzung der Inzidenz bei konkurrierenden 
Risiken sind gut etabliert, wurden aber nicht auf das oben 
beschriebene Szenario angewendet. 
Zweitens ist PICS ein komplexes Syndrom und kann durch 
verschiedene ICD-10-Codes (Internationale Klassifikation der 
Krankheiten, 10. Revision) abgebildet werden. Die Opera-
tionalisierung dieses Syndroms (Fallidentifizierung) und die 
Validierung von Fall-Definitionen sind besonders heraus-
fordernd.
Die dritte große Herausforderung ist die fehlende Dokumen-
tation des genauen Datums des interessierenden Ereignisses 
in den GKV-Routinedaten. Die vorhandenen Daten geben nur 
Aufschluss darüber, ob das Ereignis innerhalb eines bestimm-
ten Zeitraums eingetreten ist. Diese Eigenschaft wird als In-
tervallzensierung bezeichnet. Seit kurzem gibt es Methoden, 
die eine informative Zensierung aufgrund konkurrierender 
Risiken bei gleichzeitiger Intervallzensierung berücksichti-
gen. Eine weitere Alternative besteht darin die Zuordnung 
eines genauen Datums zu jeder PICS-Diagnose mithilfe von 
Verordnungsdaten zu kombinieren, denn für die Ver-
schreibung eines entsprechenden Medikamentes und/oder 
medizinischer Leistungen ist ein genaues Datum hinterlegt.
Schlussfolgerung Die Inzidenzschätzung in Post-ICU-Popu-
lationen bringt verschiedene methodische Probleme bei der 
Verwendung von GKV-Routinedaten mit sich. Wissenschaftlern 
muss das Vorhandensein von konkurrierenden Risiken bewusst 
sein. Die Anwendung interner Validierungskriterien zur Opera-
tionalisierung des interessierenden Ereignisses ist entschei-
dend, um zuverlässige Inzidenzschätzungen zu erhalten. Das 
Problem der Intervallzensierung kann entweder durch statis-
tische Methoden oder durch die Kombination von Informa-
tionen aus anderen Quellen gelöst werden.
Introduction
Treatment during intensive care has become more effective over 
the past century. This resulted in a growing population of survivors 
of critical care treatment [1]. Consequently, the number of patients 
suffering from long-term impairments associated with intensive 
care unit (ICU) treatment is increasing [2, 3]. In 2012, these “new 
or worsening impairments in physical, cognitive, or mental health 
status arising after critical illness and persisting beyond acute care 
hospitalization” were summarized as post-intensive care syndrome 
(PICS) [4]. Approximately half of patients after ICU treatment suf-
fer from some component of PICS [5]. For instance, a systematic 
review of posttraumatic stress disorder (PTSD) in ICU survivors re-
ported a prevalence of clinically diagnosed PTSD of 19 % [6]. De-
spite the growing awareness of PICS [7], epidemiological data are 
scarce and inconsistent [8], especially in Germany.
Valid estimation of the incidence of components of PICS is chal-
lenging, as it might be difficult to recruit and interview critically ill 
patients, especially a large and representative sample. Consequent-
ly, healthier ICU survivors will be overrepresented in the resulting 
data. In addition, there will be a large attrition because of the high 
mortality among ICU survivors [9]. Claims data from statutory 
health insurances (SHI) are well suited to overcome, at least in part, 
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some of these limitations [10]. The most valuable features of health 
claims data are the availability of information about a large num-
ber of persons at little cost to the researcher and the absence of re-
sponse and recall bias. Another briefly mentioned potential bias is 
selection bias. Incidence estimates derived from one sickness fund 
might not be generalizable due to structural differences between 
funds [11]. One approach to address this selection bias is using aux-
iliary data to post-stratify incidence estimates [12]. However, this 
strategy only corrects for differences in the age, sex and regional 
distributions but not for lifestyle and morbidity related factors that 
are related to the variables of interest (ICU stay, PICS) but that are 
not available in official statistics [11].
For PICS, the most valuable feature of claims data is that claims 
data delivers information on critically ill patients where the patient 
can hardly be interviewed because of his/her condition. However, 
other limitations remain when using claims data for empirical re-
search on the outcome of ICU treatment. To illustrate the method-
ological challenges and potential solutions described in this paper, 
we give an example of a study that sought to estimate the incidence 
of pneumonia in older inhabitants of nursing homes in Germany 
using claims data [13]. Patients were considered right censored 
due to end of insurance or death, and standard methodology 
(Kaplan-Meier-Estimation) was used to estimate the incidence of 
pneumonia. Thus, it was assumed that the risk was equal in cen-
sored and uncensored individuals over time. However, the cumu-
lative incidence of pneumonia would be underestimated, if the risk 
of pneumonia were higher for censored than for non-censored ob-
servations over time, and the study population under risk would 
include a progressively greater proportion of lower risk subjects.
In summary, if censoring is informative the standard methods can 
provide biased estimates. Because of the high mortality in post-ICU 
populations, PICS is subject to informative censoring and the event 
death would be seen as competing risk in this case. A competing risk 
is an event that either hinders the observation of the event of inter-
est or modifies the chance that this event occurs. ICU survivors have 
a 1-year mortality post ICU ranging from 16 to 44  % [14]. Even 5-year 
post ICU mortality is still higher (32 %) than in persons who were dis-
charged from hospital but had no ICU stay (22 %) [9]. Therefore, it is 
not possible to apply standard methods like the Kaplan-Meier (KM) 
method [15] to calculate the incidence of PICS in ICU survivors.
For this reason, we provide an explanation why methods ac-
counting for the presence of competing risks, like the cumulative 
incidence function, should be used instead of classical methods like 
the KM estimator. We also show that the application of these ad-
vanced methods entails further challenges, namely possible bias 
when the wrong case definition is used and/or when information 
on exact dates is missing. Therefore, the objective of this article is 
to describe three challenges and possible solutions for the estima-
tion of the incidence of PICS based on claims data.
Methodological challenges when investigating a 
syndrome in a cohort of ICU survivors in claims data
Challenge I: Right censoring and the competing risk 
“death”
Incidence is measured either as incidence proportion (number of 
new cases during a specific period of time / number of patients under 
risk during that time period) or incidence rate (number of new cases 
during a specific period of time / total number of person time) [16]. 
These measures differ in their type of denominators, which describe 
the population under risk. The incidence proportion uses a period of 
time during which all persons at risk were observed, whereas for the 
incidence rate, persons at risk were observed for different time pe-
riods and the denominator describes the sum of the time periods 
that each person was at risk and observed (person-time). But, some-
times, not every person has been followed for the full study period. 
This condition is called right censoring. Right censoring occurs, for 
instance, when the study ends prematurely before the event of in-
terest occurs (administrative censoring). For example, when a per-
son switched the insurer during the study period (loss to follow-up), 
or when a competing event occurs (e. g. death) [17].
If censored observations have the same probability of the event 
after censoring as those remaining under risk, it is called nonin-
formative right censoring. In populations with high mortality, this 
independence between censoring and time-to-event distributions 
cannot be assumed [18]. This type of censoring is then called in-
formative right censoring. The risk of bias is even larger in popula-
tions with persons at high risk of experiencing a competing event.
In our population of ICU survivors, informative right censoring 
due to death is a major issue as the mortality remains high even 
many years after ICU [9]. In general, competing risks are present 
when an individual can experience more than one type of event 
and the occurrence of one type of event prevents any other event 
from ever happening [19]. If the primary outcome is PICS, death 
from other causes serves as the competing risk because death be-
fore occurrence of the PICS precludes the latter event. Therefore, 
death must be considered as competing event to the occurrence 
of PICS components because persons who died were probably sick-
er and had an even higher risk to develop PICS.
In general, the term ‘time-to-event data’ is used in the medical 
literature to refer to data in which the outcome denotes time to the 
occurrence of an event of interest. The KM method for estimating 
survival functions and the Cox proportional hazards model for es-
timating the relative effect of covariates in the hazard of occurrence 
of the event are commonly used for the analysis of survival data 
(▶fig. 2). Time-to-event data are generally characterized by cen-
▶fig. 1 Competing risks multistate model. Competing risks pro-
cess with cause-specific hazards α0j, j = 1,2.
X0 = 0
α02 = (t)
α01 = (t)
discharge
(event free)
Xt = 11
event of interest
(incident PICS
component)
Xt = 22
competing event
(death)
0
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soring, i. e. the timing of the event of censored observations is un-
known. The KM method requires that censoring does not affect po-
tential failure times ( = time to event). It assumes that censoring is 
independent or noninformative [20]. However, this assumption is 
often not met when failure can occur for more than one reason.
Competing risk is a special case of multistate models in which 
each of the different events are absorbing states (▶fig. 1) [21]. Al-
though a competing risk analysis may include several types of com-
peting events, for the sake of simplicity, we focus on only one type 
of competing event in this article. There are two competing absorb-
ing states, which represent the possible event types. Occurrence 
of an event is modeled by a transition from the initial state (dis-
charge from ICU) into the corresponding event state.
Standard methods for time-to-event data typically censor sub-
jects when a competing risk occurs, and assume that competing 
risks are absent. For example, when the primary outcome is time 
to post-traumatic stress disorder, the primary outcome is censored 
when a study participant dies. However, this might violate the as-
sumption of noninformative censoring because deceased subjects 
cannot be adequately represented by uncensored subjects.
When there are no competing risks, the KM method estimates 
the survival function and its complement provides an estimate of 
the cumulative incidence of an event over time. However, when the 
KM estimator is applied in the presence of competing risk then 
there is an upward bias to be expected in the incidence. Instead, 
when estimating the incidence of an outcome in the presence of 
competing risks, suitable estimators need to be chosen. Applying 
competing risks theory allows us to connect the two initially de-
scribed measures of incidence.
Solution I: Applying competing risks theory
The most important measures for competing risk data are the cu-
mulative incidence function (CIF) [22, 23] and the cause-specific 
hazard rate [24] (▶fig. 2). The CIF is used for the estimation of the 
occurrence of an event (PICS) while accounting for competing risks 
(death). The CIF for each competing risk k gives the probability, as 
a function of time, that an event occurs in the presence of the other 
competing risks. The CIF is defined as P(T ≤ t|failure from cause k), 
for T equal to the time to first failure from cause k, and denotes the 
probability of event k before time t and before occurrence of a dif-
ferent type of event. Unlike using the complement of the KM esti-
mator, the sum of the CIFs will equal the CIF estimate of the inci-
dence of the composite outcome (PICS or death), defined as any of 
the event types. Therefore, the CIF is not biased upward like the 
KM, as the estimator is lowered by the occurrence of the compet-
ing event (dead patients can no more experience PICS). This results 
from the fact that the conditional probability of the event of inter-
est at time t is multiplied by the cumulative survival of any event. 
The cause-specific hazard is the instantaneous risk of failure from 
a specified cause given that no failure from any cause has yet oc-
curred and derived using 
lim
t
p t T t failure fromcausek T t
t


   
0
( , | )
.
t
The CIF, and its extensions to the multivariable setting, are suit-
able in situations where we are interested in incidence estimation 
and for prognostic reasons (e. g., what is an individual’s probability 
of experiencing a PICS within 12 month after discharge?, ▶fig. 2). 
Cause-specific hazards are more appropriate for addressing aetio-
logical questions (e. g., is ICU associated with the rate of occurrence 
of a diagnosis?) [25, 26]. The CIF can be estimated in R (cmprsk), 
SAS ( %CIF), and Stata (stcompet). The cause-specific hazard can 
be estimated by treating events due to competing causes as cen-
sored observations in a standard Cox model. The k cause-specific 
hazards can be derived by fitting k separate models by stacking the 
events (having k rows per individual) and fitting a Cox model strat-
ified by cause [27]. Covariates can be easily incorporated into a 
▶fig. 2 Overview of methods to use for time-to-event analysis in presence and absence of competing risks for prognostic or aetiological research 
questions. a regression adjustment for confounding
survival data/time-to-event data
competing risk
research question
aetiological
(estimation of effect)
aetiological
(estimation of effect)
· unadjusted:
 univariable causespecific
 hazards (Lunn 1995)
· adjusteda:
 multivariable causespecific
 hazards (Lunn 1995)
prognostic (prediction
of survival probability)
prognostic (prediction
of survival probability)
· unadjusted:
 Cumulative incidence
 function (Lin et al. 1997)
· adjusteda:
 Subdistribution hazard
 (Fine & Gray 1999)
· unadjusted:
 univariable Cox
 regression (Cox 1972)
· adjusteda:
 multivariable Cox
 regression (Cox 1972)
· unadjusted:
 Kaplan-Meier method
 (Kaplan & Meier 1957)
· adjusteda: (flexible)
 parametric survival model
 (e.g. Lawless 2011)
research question
yes no
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cause-specific Cox model. Multivariable models for the CIF can be 
fit on the subhazard scale, where the subhazard is the CIF trans-
formed to the hazard scale, using a Fine-Gray model [28]. Subdis-
tribution hazard models are available in R (cmprsk), SAS (PHREG), 
and Stata (stcrreg). These methods are described in detail else-
where [29, 30], for simplicity reasons they are beyond the scope 
of this paper. ▶fig. 2 provides a decision tree on how to select a 
suitable time-to-event method for individual patient data (IPD).
When analyses of prospective individual level claims data are 
not feasible (e. g. due to cost restraints or data protection issues), 
an alternative strategy is to estimate the incidence based on age-
specific cross-sectional prevalence and mortality data [31, 32]. One 
of these incidence estimation techniques makes use of the theo-
retical relationship between age-specific prevalence, incidence and 
mortality data to estimate the incidence from current status data 
to solve an ordinary differential equation. Details on the method 
are provided in [33].
No matter which approach is chosen, information about the 
type of event and the exact time to the occurrence of this event 
must be available. In order to get this information two further chal-
lenges emerge in claims data: first, how to operationalize the event 
of interest (challenge II) and second, how to define the time to 
event (challenge III).
Challenge II: Operationalization of PICS in claims data
Operationalization of the event of interest (case identification) in 
claims data requires two steps: In a first step, cases must be com-
prehensively defined based on the disease under study. A 3-digit 
ICD-10 (International Classification of Diseases, 10th Revision) code 
is usually used to specify the diagnosis. To complete the case defi-
nition, the possible sectors (e. g. inpatient, outpatient, or incapac-
ity for work data) in which these codes were documented must be 
defined. In a second step, we have to validate the case definition. 
Physicians in Germany code outpatient diagnoses as “ruled out”, 
“asymptomatic”, “suspected”, and “confirmed”. In most cases, it 
is more reliable to use “confirmed” outpatient diagnoses. Inpatient 
diagnoses are divided into a (main) discharge diagnosis and sec-
ondary diagnoses. Internal validation is strongly recommended for 
diagnoses from both sectors [34].
Applying the criterion of “at least two quarters” (M2Q), is prob-
ably one of the best-known validation approaches to reflect persis-
tence of diagnosis. This criterion requires a confirmative diagnosis 
in at least one further quarter or a second diagnosis by another phy-
sician in the same quarter [35, 36].
Both, the case definition and the validation, are particularly chal-
lenging in an ICU survivor population for several reasons. First, no 
agreement on a list of ICD-codes exists to define the PICS and, ad-
ditionally, the diseases included in the PICS syndrome are not gen-
erally agreed by experts [7]. Second, all health care sectors are of 
interest to assess the incidence of the diseases after ICU stay. Many 
patients are admitted to a rehabilitative care after discharge from 
ICU. In terms of rehabilitation stays, limited information is availa-
ble in the data from the SHI. Third, internal validation strategies, 
which are based on measures of persistence, might not be the most 
suitable approach for a patient group that has a high lethality. Thus, 
applying M2Q to sicker patients who are censored because they 
died will result in downwardly biased incidence estimates.
Solution II: Reporting single components of PICS that were 
validated with measures of congruence
Until now, there is neither consensus on the definition of the PICS 
nor is there a list of ICD-10 codes available to define specific com-
ponents of the PICS. In this situation, we propose to apply a case-
identifying algorithm that is based on ICD-10 codes, which reflect 
the PICS and capture all three domains covered by PICS: physical, 
mental and cognitive impairments [4]. The current selection of 
ICD-10 codes, which represent PICS components, should be based 
on literature [4, 37, 38] and be informed by expert consultation 
with intensive care clinicians.
Because M2Q like other criteria of persistence are not applica-
ble, the criteria of congruence can be used to validate (confirmed) 
diagnoses. As confirmed diagnoses alone can include false positive 
diagnoses [34], the second approach is to use information on pre-
scriptions (e. g. ATC (Anatomical Therapeutic Chemical) Classifica-
tion System codes or EBM-Codes (Einheitlicher Bewertungs-
maßstab, meaning outpatient physician̓s service codes of the Ger-
man outpatient fee-for-service reimbursement system)) as a 
measure of congruence. For instance, a diagnosis of dementia can 
be assumed when a patient is diagnosed with one of the respective 
ICD-10 codes in the inpatient or outpatient sector and when a pre-
scription of antidementiva ATC code is also reported.
In summary, depending on the respective goal, two possible 
ways are plausible to define cases: we can apply more sensitive, but 
less restrictive selection criteria to ensure full coverage of true pos-
itive cases or we use less sensitive, but more restrictive criteria to 
avoid the inclusion of false positives. Previous studies countered 
this issue by providing results with different case definitions in sen-
sitivity analyses [35, 39].
Challenge III: Interval Censoring
The data of SHI are also affected by interval censoring (▶fig. 3). 
Interval censoring describes that the exact time of diagnosis is un-
known, it is only known to lie within an interval. In outpatient claims 
data, which are forwarded on a quarterly basis no exact date for 
▶fig. 3 Censoring in data of statutory health insurers.
exact event time
e.g. date of death, date of prescription
0 (discharge)
Xi = Ti
right censoring
e.g. end of study, death
0 (discharge)
Xi = Ci Ti
interval censoring
e.g. quarterly
outpatient diagnoses
0 (discharge)
X1 = T1 T2T1
*Xi = observed time point
 Ti = event time
 Ci = censoring time
*T1,2 = fixed points of time marking metric
 intervals like e.g. calendrical quarters in
 outpatient data (censoring can take
 place at any of these points of time)
S105
Brandl M et al. Incidence Estimation in Post-ICU … Gesundheitswesen 2020; 82 (Suppl. 2): S101–S107
Original Article Thieme
outpatient diagnoses is known. Likewise, for inpatient diagnoses 
only the date of admission and discharge from the hospital is 
known. More generally, data of this type typically arise in studies 
where follow up is done at fixed intervals. In the context of interval 
censoring, many researchers use imputation techniques, especial-
ly mid-point or right-point imputation (i. e., replacing an interval 
censored observation by its right endpoint), and then apply stand-
ard techniques for right censored data [40]. However, these ap-
proaches may not be appropriate. Imputation approaches propose 
an estimate for an unknown distribution, and obtain biased esti-
mates and standard errors, especially if the intervals are wide, by 
falsely assuming that the time of event is equal to the right-point 
or mid-point of the time interval [41]. Special techniques for inter-
val-censored data should therefore be preferred, as will be seen 
later in this section. Alternatively, the underlying continuous dura-
tions can be conceptualized as a latent variable with observed dis-
joint (discrete) time intervals [42]. A related methodological issue 
arises when the time of the study entry was date of hospital dis-
charge, and a patient’s hospital stay took place in one quarter. In 
this case, it is unknown whether an outpatient diagnosis document-
ed per quarter was coded before or after the hospital stay (see 
▶fig. 4).
Solution III: Approximation of the exact date
A conceivable solution might be to associate an existing date with 
a diagnosis and use this date as the diagnostic date and apply stand-
ard techniques for right-censored data. For this purpose, we could 
use the exact date of an outpatient physician visit or use the date 
of a PIC-specific procedure that was coded using the uniform eval-
uation scale (EBM, “Einheitlicher Bewertungsmaßstab”), an exact 
prescription date of a medication or of a non-pharmaceutical ther-
apy or technical aid in the data of the SHI. In case of less disease 
specific medications (such as pain killers) the date of medication 
cannot be used to approximate the date of diagnosis. In this sce-
nario, dates of physician visits can be considered. Dates attached 
to physician visits are not as specific as prescription dates, as pa-
tients may have several encounters with an outpatient care pro-
vider during one quarter. In this case, we consider the first and last 
visit of the patient during a quarter and code the middle of this pe-
riod to further limit the period of diagnoses. Certain outcomes 
could possibly be indicated by a physician visit with a specific EBM 
code. If so, these outcomes’ incidence could be measured by the 
exact date of the physician visit with the delivered EBM-code and 
not only by the time frame spanned by multiple physician visits. 
There are new statistical methods allowing to model competing 
risk data in combination with interval censoring [43]. These tech-
niques can provide more exact dates for a relevant part of the sam-
ple. However, the allocation of the diagnosis within the quarter of 
the hospital stay is still not satisfactorily solved.
Conclusion
A better understanding of patients’ health after ICU is urgently 
needed. Claims data are a valuable data source for advancing the 
scientific knowledge about PICS. However, various methodologi-
cal issues have to be accounted for when analyzing health claims 
data of post-ICU populations. Investigators need to be aware of the 
presence of competing risks when performing time-to-event anal-
ysis in studies with highly morbid patient groups. The internal val-
idation of diagnoses in health claims data, and techniques to im-
pute or approximate exact dates of diagnoses are crucial to achieve 
reliable estimates of frequency. Incorrectly treating competing 
events as censored events may have practical implications for pa-
tient care or health care planning.
To minimize bias when estimating incidences, investigators can 
use the cumulative incidence function or cause-specific hazards to 
estimate the incidence of PICS or other diseases in highly morbid 
patient groups subject to competing risk.
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